Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardium

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 9, Issue 4, 2004, Pages 279-289

  Schwarz, Ernst R ^a,b   Meven, Dennis A ^a   Sulemanjee, Nasir Z ^b   Kersting, Philipp H ^a   Tussing, Tanja ^a   Skobel, Erik C ^a   Hanrath, Peter ^a   Uretsky, Barry F ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Angiogenesis; Arteriogenesis; MCP 1; Myocardial infarction; Rats

Indexed keywords

DYE; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VAN GIESON STAIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INFILTRATION; CELL INVASION; CHRONICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; LEFT CORONARY ARTERY; MICROSCOPY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; STAIN; STAINING; TISSUE PERFUSION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; MONOCYTES; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 12344304601     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840400900408     Document Type: Article

References (25)

1. Kersten JR, Pagel PS, Chilian WM, et al. Multifactorial basis for coronary collateralization: A complex adaptive response to ischemia. Cardiovasc Res 43:44-57, 1999
2. Schaper W. Quo vadis collateral blood flow? A commentary on a highly cited paper. Cardiovasc Res 45:220-223, 2000
3. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911-919, 1996
4. Banai S, Shweiki D, Pinson A, et al. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 28:1176-1179, 1994
5. Hashimoto E, Ogita T, Takashi N, et al. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267:H1948-H1954, 1994
6. Schwarz ER, Speakman MT, Patterson M, et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol 35:1323-1330, 2000
7. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in an canine model. Am J Physiol 266:H1588-H1595, 1994
8. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor on coronary collateral development and the arterial response to injury. Circulation 94:1074-1082, 1996
9. Laham RJ, Rezaee M, Post M, et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 292:795-802, 2000
10. Laham RJ, Hung D, Simons M. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery. Clin Cardiol 22(Suppl I):I-6-I-9, 1999
11. Kluge A, Zimmermann R, Münkel B, et al. Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart. Cardiovasc Res 29:407-415, 1995
12. Kluge A, Zimmermann R, Weihrauch D, et al. Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc Res 33:324-331, 1997
13. Ito WD, Arras M, Winkler B, et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829-837, 1997
14. Kakio T, Matsumori A, Ono K, et al. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest 80: 1127-1136, 2000
15. Jost MM, Ninci E, Meder B, et al. Divergent effects of GM-CSF and TGF {beta}1 on bone marrow-derived macrophage arginase-1 activity, MCP-1 expression, and matrix metalloproteinase-12: A potential role during arteriogenesis. FASEB J 17:2281-2283, 2003
16. Heil M, Ziegelhoeffer T, Pipp F, et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol (Heart Circ Physiol) 283:H2411-2419, 2002
17. Sellke FW, Simons M. Angiogenesis in cardiovascular disease. Current status and therapeutic potential. Drugs 58:391-396, 1999
18. Sellke FW, Li J, Stamler A, et al. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120:182-188, 1996
19. Kornowski R, Leon MB, Fuchs S, et al. Electromagnetic guidance for catheter-based transendocardial injection: A platform for intramyocardial angiogenesis therapy. J Am Coll Cardiol 35:1031-1039, 2000
20. Post MJ, Laham R, Selke FW, et al. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 49:522-531, 2001
21. 165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804, 1998
22. Hendel RC, Henry TD, Rocha-Singh K, et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion. Evidence for a dose-dependent effect. Circulation 101:118-121, 2000
23. 165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102:965-974, 2000
24. 165 in patient with ischaemic limb. Lancet 348:370-374, 1996
25. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123, 1998